ACE2 and COVID-19: In summary, we have demonstrated that ASOs targeting the SARS-CoV-2 host entry factor ACE2 and SARS-CoV-2 genome can effectively inhibit cellular infection by various strains of SARS-CoV-2 in vitro, suggesting ASOs might be useful tools to prevent and reduce the burden of COVID-19 (Fig 4B).